Screener
Neogen NEOG Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Neogen in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Neogen’s 10-Q, filed April 9, 2026.
- Filed
- Apr 9, 2026, 4:03 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-149599
| Assets | February 28, 2026 / (unaudited) | May 31, 2025 |
|---|---|---|
| Current Assets | ||
| Cash and cash equivalents | $159.9 | $129.0 |
| Accounts receivable, net of allowance of $4.1 and $5.4 | 137.1 | 153.4 |
| Inventories | ||
| Raw materials | 55.6 | 65.7 |
| Work-in-process | 9.3 | 11.2 |
| Finished goods | 113.3 | 130.4 |
| Total Inventories | 178.2 | 207.3 |
Item 1. Interim Condensed Consolidated Financial Statements
FAQ
- What is Neogen's cash & equivalents?
- Neogen (NEOG) reported cash & equivalents of $159.9M in Q4 2025.
- How has Neogen's cash & equivalents changed year-over-year?
- Neogen's cash & equivalents increased by 25.2% year-over-year, from $127.71M to $159.9M.
- What is the long-term trend for Neogen's cash & equivalents?
- Over 4 years (2021 to 2025), Neogen's cash & equivalents has grown at a 14.3% compound annual growth rate (CAGR), from $75.6M to $129M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Neogen's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude